Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 SEK | +3.45% | -6.25% | -62.45% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 109M 1.19B |
---|---|---|---|---|---|
Net income 2022 | -76M -829M | Net income 2023 | -39M -425M | EV / Sales 2022 | - |
Net cash position 2022 | 76.01M 829M | Net cash position 2023 | 26.02M 284M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.99
x | P/E ratio 2023 |
-2.78
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.68% |
Latest transcript on Scandion Oncology A/S
1 day | +3.45% | ||
1 week | -6.25% | ||
Current month | -40.24% | ||
1 month | -40.24% | ||
3 months | -65.71% | ||
6 months | +25.00% | ||
Current year | -62.45% |
Managers | Title | Age | Since |
---|---|---|---|
Jan Stenvang
FOU | Founder | - | 16-12-31 |
Chief Executive Officer | 64 | 23-01-01 | |
Johnny Stilou
DFI | Director of Finance/CFO | 57 | 21-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 22-03-31 | |
Director/Board Member | 69 | 18-05-06 | |
Martin Møller
CHM | Chairman | 49 | 21-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.5 | +3.45% | 37,251 |
24-04-25 | 1.45 | +4.32% | 40,968 |
24-04-24 | 1.39 | -3.81% | 109,713 |
24-04-23 | 1.445 | -9.12% | 93,277 |
24-04-22 | 1.59 | -0.63% | 73,490 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 11:11 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-62.45% | 5.57M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- SCOL Stock